Navigation Links
Good News for Sufferers of Heart Attack, Chest Pain

he heart and angioplasty as an emergency or secondary treatment to reopen blockages increased by more than 30 percent in STEMI patients and around 20 percent in ACS patients.

As the use of all these treatments increased, the death rate for patients both in the hospital and in their first six months after going home decreased significantly. So did the risk that patients would develop heart failure, have pulmonary edema, or suffer a stroke in their first six months after hospitalization.

"These findings are exciting because they provide good evidence that improved use of guideline- based treatments has resulted in fewer deaths and fewer patients with heart failure in those that present to hospital with heart attack or threatened heart attack," says Keith A. A. Fox, MB. ChB., FRCP, lead author of the paper, co-chair of GRACE and a professor of cardiology at Edinburgh.

"These data are extremely encouraging, and suggest that we're definitely improving heart care and patients' outcomes through the uniform use of evidence-based, proven treatments and the development of guidelines to help providers understand the evidence behind them," says Kim Eagle, M.D., FACC, a co-author on the paper and co-chair of the publication committee for GRACE. He is the Albion Walter Hewlett Professor of Cardiovascular Medicine at the U-M Medical School and a director of the U-M Cardiovascular Center.

"Yet, these data and other studies show that we still have a ways to go before every heart attack and ACS patient receives the full range of tests and treatments that we know can benefit them," Eagle continues. He notes, for example, that only 85 percent of STEMI patients and 83 percent of ACS patients in the study received a statin in 2006, when virtually all such patients should receive the cholesterol-lowering drug. And only 53 percent of STEMI patients received emergency angioplasty, when it has repeatedly been shown to be life-saving in
'"/>




Page: 1 2 3 4

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Do Asthma Sufferers Lack Physical Activity?
3. Asthma Sufferers Lacking Physical Activity
4. Hope for Dust Mite Allergy Sufferers
5. Promise for Soya Allergy Sufferers
6. AIDS Sufferers Protest against Proposed Patent for Tenofovir
7. Zambia Struggling To Identify AIDS Sufferers
8. Celiac Disease Sufferers See an End to their Misery
9. AIDS Sufferers Turn to British Doctor to Prolong their Survival
10. Exercise DVD Available For COPD Sufferers
11. Sleep Apnea Sufferers-Viagra May Make The Condition Worse
Post Your Comments:
(Date:10/11/2008)...Setback and Expects the 89-Year-Old ...C., Oct. 11 /PRNewswire/ -- Evangelist Billy Graha....C. upon his release this,afternoon from Mission H....,He was admitted for observation after he tripped... Mr. Graham,s physicians said that he suffered no...
(Date:10/10/2008)...isease by 20 years after operation, study says , ...er transplant patients have a higher incidence of ...s in Finland. , In a new study published in th...chers investigated the cancer risk pattern in 540 ...University Central Hospital. The patients were giv...
(Date:10/10/2008)... -- Do you think that the blind,can,t use computer...ctober,17 open house at the Virginia Rehabilitatio...e how instructors there empower the blind and,visu... through non-visual,techniques taught at the cente...holding an open house to,celebrate the grand openi...
(Date:10/10/2008)...e/ -- NuView Life Sciences Inc.,(NuView) has agree...,(Trace), including operations of the linear accel...on, Texas. The Trace facility produces,Copper-64, ...1 used in,molecular imaging and nuclear medicine. ...We are confident that by improving operational,eff...
Breaking Medicine News(10 mins):Health News:Billy Graham Returns Home Following Hospital Observation 2Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2
...h domestic consumption of wine halved in France si...r has turned to emerging market exports as its sav... feted at this year's Vinexpo wine trade show, the...ending the two-yearly event who warn against both ...
...tnam plans to start its first human trial of a loc...onth, using 20 to 30 volunteers, said health offic... be carried out with US government technical assis...ts to develop a vaccine for mass production, with ...
...rief encounter with a Jewish prostitute might have..., according to a new study by psychiatrists. Hitl... untreated, led to his madness and eventually targ...he mentally retarded. There is "ample circumstant...
...ian pharma major Wockhardt Wednesday announced the... US after receiving approval from the US Food and ...losporin class of antibiotics, is used in the trea...act and skin infections. "Several of our product...
Other Medicine News:Health News:Go for Russia, Not China, Wine Experts Say 2Health News:Go for Russia, Not China, Wine Experts Say 3Health News:Vietnam Plans Human Trial of Bird Flu Vaccine 2Health News:Hitler's Holocaust may Have Stemmed from Syphilis from Jewish Prostitute 2
(Date:10/9/2008)...es for Increased Sales and Marketing Efforts to Ac...lip(R) System, MENLO PARK, Calif., Oct. 9 /PRNews...nt of devices for the percutaneous repair of cardi...ecutive team with the appointment of,Sean Cleary a...keting and,Chris Richardson, as vice president of ...
(Date:10/9/2008)...ctober 9 /- Diamyd Medical ...journal, the New England Journal,of Medicine, has ...,s study,of the Diamyd(R) diabetes vaccine for typ...-bin/prnh/20080314/297194 ), The article is now ...ejm.org ) and will be in print on October 30. It p...
(Date:10/8/2008)...ay Someday Inform Treatments for Spinal Cord, Othe...ire-USNewswire/ -- A protein that enables,nerve ce...e in controlling,the developing nervous system. Re...ions to form among nerve cells may provide a basis...njuries to their nervous system,including spinal ...
(Date:10/8/2008)...iversity Food Scientists Expand Testing Using Cell...say, PORTLAND, Maine, Oct. 8 /- Wild...h the release of results from a new study,showing ...ly consumed,fruits like apples, bananas, red grape...ellular Antioxidant Activity (CAA) assay. New rese...
Breaking Medicine Technology:Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3CIHR announces 244 4 million to improve mental health of Canadians 24200 1CIHR announces 244 4 million to improve mental health of Canadians 24200 2Averting postsurgical infections in kids 3A Give antibiotics within hour before first incision 24197 1Averting postsurgical infections in kids 3A Give antibiotics within hour before first incision 24197 2Highmark Blue Cross Blue Shield United Concordia and Catholic Charities Join Forces to Offer Free Health Dental Services This Saturday 24194 1Highmark Blue Cross Blue Shield United Concordia and Catholic Charities Join Forces to Offer Free Health Dental Services This Saturday 24194 2Gene Variations May Predict Antidepressant Response 24193 1Gene Variations May Predict Antidepressant Response 24193 2
...l Studies Suggest FTY720 Mechanisms in Multiple,Sc... · Preclinical studies suggest FTY720 stimu... and enhance repair of the,CNS affected by multipl...he six-month multiple,sclerosis Phase II clinical ...linical depression was significantly lower in the,...
..., N.J.--(BUSINESS WIRE)--May 4, 2007 - Lux Bioscie... specialized in the,field of ophthalmic diseases, ... calcineurin inhibitor, LX211, is the subject of t...n Vision and,Ophthalmology (ARVO) annual meeting, ...The first, an oral presentation being given on May...
Other Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4
The ENDOLOOP consists of 18'' long ligature inserted into a plastic tube. The plastic tube is narrow at one end and scored on the other. The suture protrudes from the narrow end and is formed in a li
VIDAS tests are presented in individual, ready to use form. Each test is composed of a strip and a SPR. The strip contains all the reagent required for the reaction (buffer, conjugate and substrate.
Clostridium difficile Toxin A Rapydtest® is a fast, simple and highly sensitive test for the rapid and reliable detection of C. difficile Toxins A in faeces.
The RC-4000 guarantees precise and efficient multi-diagnostic measurement by combining keratometry, refraction, refraction/keratometry and contact lens base curve measurement.
Medicine Products: